跳至主要内容
临床试验/NCT05485051
NCT05485051已完成3 期

Impact of Chlorhexidine Bath on Healthcare-associated Infections Acquisitions in Intensive Care Units - A Cluster Randomized Trial

Hospital do Coracao17 个研究点 分布在 1 个国家目标入组 15,730 人开始时间: 2022年8月3日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
15,730
试验地点
17
主要终点
Composite of healthcare-associated infections (HAI)

研究概览

简要总结

Cluster randomized controlled trial comparing two bathing strategies in critically ill patients. The intervention group will receive daily bathing with chlorhexidine. The control group will receive usual care.

详细描述

Healthcare-associated infections (HAI) are common complications in critically ill patients and are associated with increased costs, higher length of stay, and higher morbimortality. Data shows that daily chlorhexidine baths might be associated with lower HAI rates in a broad population of critically ill patients. The purpose of this trial is to evaluate the effect of daily bathing with chlorhexidine compared to usual baths (soap and water) on HAI in critically ill patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients ≥ 18 years/old admitted to the participants's ICUs

排除标准

  • History of chlorhexidine allergy

结局指标

主要结局

Composite of healthcare-associated infections (HAI)

时间窗: Within each cluster duration (90 days)

Composite outcome of the following HAI: Ventilator associated pneumonia (VAP) Central line-associated blood stream infections (CLABSI) Catheter-associated urinary tract infection (CAUTI)

次要结局

  • Ventilator associated pneumonia (VAP)(Within each cluster duration (90 days))
  • Central line-associated blood stream infections (CLABSI)(Within each cluster duration (90 days))
  • Catheter-associated urinary tract infection (CAUTI)(Within each cluster duration (90 days))
  • Hospital length of stay(Until hospital discharge, maximum 90 days)
  • In hospital mortality(Maximum 90 days after randomization)
  • Rates of multi-drug-resistant pathogens(Within each cluster duration (90 days))
  • Antibiotic use(Within each cluster duration (90 days))
  • Intensive Care Unit length of stay(Until Intensive Care Unit discharge, maximum 90 days)
  • Intensive Care Unit mortality(Maximum 90 days after randomization)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (17)

Loading locations...

相似试验

Daily Chlorexidine Bath for Health Care Associated... | 临床试验